Radionuclide evaluation of pleural-peritoneal shunt before pleurodesis

Clin Nucl Med. 2004 Sep;29(9):545-7. doi: 10.1097/01.rlu.0000134980.57598.5d.

Abstract

Objectives: Talc pleurodesis can be offered to patients with hepatic hydrothorax. The authors wanted to determine their patient's eligibility for talc pleurodesis by excluding a pleural-peritoneal shunt.

Materials and methods: The authors measured the size of the talc particles and matched them with the radionuclide particle size. After injecting radiopharmaceutical into the pleura, the authors imaged the abdomen for possible migration.

Results: In their patient, there was no migration of radionuclide from the thorax into the abdomen.

Conclusion: Injecting radionuclide into the thoracic cavity and then imaging for an extended period of time is one way to determine whether the patient has a pleural-peritoneal shunt.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Humans
  • Hydrothorax / diagnostic imaging*
  • Hydrothorax / drug therapy
  • Hydrothorax / surgery
  • Injections, Intraperitoneal
  • Liver Diseases / diagnostic imaging*
  • Liver Diseases / drug therapy
  • Liver Diseases / surgery
  • Patient Selection
  • Peritoneovenous Shunt / methods
  • Pleurodesis / methods
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Talc / administration & dosage
  • Technetium Tc 99m Sulfur Colloid / administration & dosage*

Substances

  • Radiopharmaceuticals
  • Talc
  • Technetium Tc 99m Sulfur Colloid